Pradžia › Meduloblastoma
Meduloblastoma klinikiniai tyrimai JAV ieško dalyvių
24 tyrimai dėl Meduloblastoma ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Washington, DC9 tyrimai
- St. Louis, MO6 tyrimai
- Houston, TX4 tyrimai
- New York City, NY4 tyrimai
- Miami, FL4 tyrimai
- Durham, NC4 tyrimai
- Seattle, WA4 tyrimai
- Philadelphia, PA4 tyrimai
- Tampa, FL4 tyrimai
- Memphis, TN3 tyrimai
- Chicago, IL3 tyrimai
- Cincinnati, OH3 tyrimai
- Boston, MA3 tyrimai
- Ann Arbor, MI3 tyrimai
- Columbus, OH3 tyrimai
- Hartford, CT3 tyrimai
- Charlotte, NC3 tyrimai
- San Francisco, CA3 tyrimai
- Austin, TX3 tyrimai
- Little Rock, AR3 tyrimai
- St. Petersburg, FL3 tyrimai
- Minneapolis, MN3 tyrimai
- Orlando, FL3 tyrimai
- San Diego, CA3 tyrimai
- Dallas, TX3 tyrimai
- Mountain View, CA3 tyrimai
Pagal valstiją
- Alabama3 tyrimai
- Arkansas3 tyrimai
- Džordžija3 tyrimai
- Florida6 tyrimai
- Ilinoisas3 tyrimai
- Kalifornija6 tyrimai
- Kentukis3 tyrimai
- Kolumbijos apskritis7 tyrimai
- Konektikutas3 tyrimai
- Masčusetsas3 tyrimai
- Merilendas4 tyrimai
- Minesota3 tyrimai
- Misūris6 tyrimai
- Mičiganas4 tyrimai
- New Jersey3 tyrimai
- New York5 tyrimai
- North Carolina4 tyrimai
- Ohio3 tyrimai
- Pennsylvania5 tyrimai
- Tennessee5 tyrimai
- Texas8 tyrimai
- Washington4 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
Renkami dalyviai1/2 fazė
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07346157Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback
Renkami dalyviai
Amžius nuo 10 iki 25 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07830134Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Renkami dalyviai2 fazė
59 Months · Visoms lytims · Atnaujinta 2026-09-15 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Renkami dalyviai1 fazė
Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07087002Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Renkami dalyviai2 fazė
Iki 19 metų · Visoms lytims · Atnaujinta 2026-09-10 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Renkami dalyviai1 fazė
36 Months – 22 Years · Visoms lytims · Atnaujinta 2026-09-04 · NCT03911388B7-H3.CD28Z.CART in CNS Neoplasms
Renkami dalyviai1 fazė
Amžius nuo 2 iki 21 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07390539Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 3 iki 50 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07242963Digoxin Medulloblastoma Study
Renkami dalyviai2 fazė
12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-26 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Renkami dalyviai3 fazė
Amžius nuo 4 iki 21 · Visoms lytims · Atnaujinta 2026-08-25 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Renkami dalyviai2 fazė
Amžius nuo 3 iki 39 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05096481PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-08-12 · NCT06161519DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Renkami dalyviai2 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-12 · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Renkami dalyviai
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-08-11 · NCT05057702Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
Renkami dalyviai1 fazė
Amžius nuo 4 iki 30 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06514898Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Renkami dalyviai1 fazė
Amžius nuo 2 iki 25 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06624371Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Renkami dalyviai1/2 fazė
Amžius nuo 4 iki 39 · Visoms lytims · Atnaujinta 2026-07-20 · NCT05278208A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
Renkami dalyviai1 fazė
Amžius nuo 3 iki 22 · Visoms lytims · Atnaujinta 2026-07-13 · NCT07698899CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-06 · NCT07085325Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Renkami dalyviai1 fazė
Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-06-17 · NCT06193759Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Renkami dalyviai1 fazė
Amžius nuo 1 iki 26 · Visoms lytims · Atnaujinta 2026-04-13 · NCT04185038Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Renkami dalyviai1 fazė
Amžius nuo 3 iki 25 · Visoms lytims · Atnaujinta 2026-01-09 · NCT05106296Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-18 · NCT0454108268-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Renkami dalyviai4 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2025-11-21 · NCT04081701Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.